• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

Lupin’s Nagpur facility inspection concludes with no observation

financialexpressSeptember 17, 2018

Tag: Inspection , lupin , Nagpur facility

Pharma major Lupin announced recently the successful completion of an inspection carried out by the US FDA at its Nagpur, Maharashtra, India facility. The inspection concluded without any observation. This inspection was a product specific pre-approval inspection.

Lupin’s Nagpur facility is the company’s latest site and manufactures Oral Solid Dosage products. The site also houses Lupin’s state of the art injectable manufacturing facility.

-----------------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.

 

Previous:Lupin receives FDA approval for generic Atovaquone Oral Solution USP

Next:Merck extends I/O lead as EU Oks Keytruda in first line lung cancer

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Lupin’s Nagpur facility inspection concludes with no observation | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

Sampo —— Sample Print Inspection and Proofing Machine

Sampo —— Sample Print Inspection and Proofing Machine
automatic ampoule inspection machine

automatic ampoule inspection machine
Inspection Machine Model YJ-90A For Vials, Ampoule

Inspection Machine Model YJ-90A For Vials, Ampoule
StarInline —— Inspection Machine Inline to Folder Gluer

StarInline —— Inspection Machine Inline to Folder Gluer
Vials Inspection Machine Model YJA-90Y

Vials Inspection Machine Model YJA-90Y
AIS Series Light Inspection Machine

AIS Series Light Inspection Machine
JAZ600/20 Ampoule Automatic Impurity Inspection Machine

JAZ600/20 Ampoule Automatic Impurity Inspection Machine
Capsule Inspection Machine Model CI5F

Capsule Inspection Machine Model CI5F
JAZ800/5 Automatic Ampoule Impurity Inspection Machine

JAZ800/5 Automatic Ampoule Impurity Inspection Machine
CSSY Inspection analysis ultra pure water system with biochemical analyzer

CSSY Inspection analysis ultra pure water system with biochemical analyzer

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service